Aclaris therapeutics - on oct. 15, company, rigel pharmaceuticals entered first amendment to license & collaboration agreement dated aug. 27, 2015

Aclaris therapeutics - on oct 15, co, rigel pharmaceuticals entered first amendment to license & collaboration agreement dated aug 27, 2015.aclaris therapeutics - under amendment, co & rigel to eliminate certain development milestones.aclaris therapeutics - also agreed to pay rigel an amendment fee of $1.5 million.aclaris therapeutics inc - under amendment rigel released co from any obligation to pay a milestone payment for milestones.aclaris therapeutics - co agreed to increase potential payments payable upon achievement of certain milestones from $10 million to $10.5 million in aggregate.
ACRS Ratings Summary
ACRS Quant Ranking